Cancer development in renal allograft recipients treated with conventional and cyclosporine immunosuppression
Gruber, S.A.; Skjei, K.L.; Sothern, R.B.; Robison, L.; Tzardis, P.; Moss, A.; Gillingham, K.; Canafax, D.M.; Matas, A.J.; Dunn, D.L.
Transplantation Proceedings 23(1 Pt 2): 1104-1105
1991
ISSN/ISBN: 0041-1345 PMID: 1989160 Document Number: 373238
Document emailed within 1 workday
Related Documents
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112Fung, J.J.; Todo, S.; Tzakis, A.; Demetris, A.; Jain, A.; Abu-Elmaged, K.; Alessiani, M.; Starzl, T.E. 1991: Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls Transplantation Proceedings 23(1 Part 1): 14-21
Yokota, K.; Fukumitsu, M.; Kuzuhara, K.; Otsubo, O.; Tomikawa, S.; Nagao, T.; Uchida, H.; Sato, K.; Nakayama, Y.; Endo, T. 1994: Development of cancer in renal allograft recipients Transplantation Proceedings 26(4): 1977-1978
Rigotti, P.; Flechner, S.M.; Van Buren, C.T.; Payne, W.T.; Kahan, B.D. 1986: Increased incidence of renal allograft thrombosis under cyclosporine immunosuppression International Surgery 71(1): 38-41
Delmonico, F.L.; Knowles, R.W.; Colvin, R.B.; Cavender, D.E.; Kawai, T.; Bedle, M.; Stroka, D.; Preffer, F.I.; Haug, C.; Cosimi, A.B. 1993: Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies Transplantation Proceedings 25(1 Part 1): 784-785
Carpenter, C.B.; Milford, E.L.; Kirkman, R.L.; Strom, T.B.; Lazarus, J.M.; Tilney, N.L. 1985: Stability of renal allograft recipients after conversion from cyclosporine to azathioprine Transplantation Proceedings 17(4 Suppl 1: 261-265
O'Connell, P.; d'Apice, A.; Walker, R.; Francis, D.; Kincaid-Smith, P. 1988: Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone Transplantation Proceedings 20(1): 11-13
MacDonald, A.S.; Daloze, P.; Dandavino, R.; Jindal, S.; Bear, L.; Dossetor, J.B.; Klassen, J.; Stiller, C.R.; Lockwood, B.; Reeve, C.E. 1987: A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group Transplantation Proceedings 19(1 Part 3): 1865-1866
Kahan, B.D.; Kramer, W.G.; Williams, C.; Wideman, C.A. 1986: Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients Transplantation Proceedings 18(6 Suppl 5: 200-203
Buturović, J.; Kandus, A.; Malovrh, M.; Bren, A.; Drinovec, J. 1990: Cyclosporine-associated hemolytic uremic syndrome in four renal allograft recipients: resolution without specific therapy Transplantation Proceedings 22(4): 1726-1727
Kelly, J.J.; Walker, R.G.; d'Apice, A.J.; Kincaid-Smith, P. 1990: A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results Transplantation Proceedings 22(5): 2127-2128
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G. 1988: No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience Transplantation Proceedings 20(3 Suppl 3: 261-263
Widmer, U.; Frei, D.; Keusch, G.; Burger, H.R.; Largiader, F.; Binswanger, U. 1988: OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine a Transplantation Proceedings 20(5 Suppl 6: 90-95
Homan van der Heide, J.J.; Bilo, H.J.; Donker, A.J.; Wilmink, J.M.; Sluiter, W.J.; Tegzess, A.M. 1992: The effects of dietary supplementation with fish oil on renal function and the course of early postoperative rejection episodes in cyclosporine-treated renal transplant recipients Transplantation 54(2): 257-263
Mihatsch, M.J.; Thiel, G.; Basler, V.; Ryffel, B.; Landmann, J.; von Overbeck, J.; Zollinger, H.U. 1985: Morphological patterns in cyclosporine-treated renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 101-116
Carmellini, M.; Romagnoli, J.; Pietrabissa, A.; Di Stefano, R.; Oleggini, M.; Rindi, P.; Rizzo, G.; Mosca, F. 1994: Evaluation of infections in renal transplant recipients treated with cyclosporine Transplantation Proceedings 26(5): 2658-2659
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Sonoda, K.; Meek, A.G.; Strober, S.; Hayashi, R.; Ishimaru, M.; Rapaport, F.T. 1989: Synergistic efficacy of staged total lymphoid irradiation and cyclosporine in the preoperative preparation of high-risk hyperimmunized canine renal allograft recipients Transplantation Proceedings 21(1 Pt 1): 1116-1117
Vathsala, A.; Woo, K.T. 1999: Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital Clinical Transplants 1999: 189-197
Kerman, R.H.; Van Buren, C.T.; Lewis, R.M.; Kahan, B.D. 1988: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients Transplantation Proceedings 20(3 Suppl 3: 264-269